TCF National Bank’s Bristol-Myers Squibb BMY Stock Holding History

TCF National Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$2.69M	Sell	42,684 -6,230	-13%	-$388K	0.31%	82
2020 Q4	$3.03M	Buy	48,914 +2,134	+5%	+$131K	0.32%	75
2020 Q3	$2.82M	Buy	46,780 +13,537	+41%	+$815K	0.33%	75
2020 Q2	$1.51M	Sell	33,243 -5,400	-14%	-$323K	0.17%	134
2020 Q1	$2.15M	Buy	38,643 +580	+2%	+$35.5K	0.32%	75
2019 Q4	$2.44M	Buy	38,063 +5,202	+16%	+$298K	0.28%	89
2019 Q3	$1.67M	Buy	+32,861	New	+$1.54M	0.2%	116

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCF National Bank's BMY Position: Q1 2021 in Review

TCF National Bank reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2021, selling an estimated $388K and leaving 42,684 shares worth $2.69M. The position accounts for 0.31% of the portfolio, ranked #82.

TCF National Bank first reported a position in BMY in Q3 2019 and has held it in 7 quarters since. The position peaked at $3.03M in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

TCF National Bank held 42,684 shares of Bristol-Myers Squibb worth $2.69M as of Q1 2021.
TCF National Bank sold 6,230 Bristol-Myers Squibb shares in Q1 2021, an estimated $388K.
Bristol-Myers Squibb made up 0.31% of TCF National Bank's portfolio in Q1 2021, its #82 holding.
TCF National Bank first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 7 quarters since.
TCF National Bank's Bristol-Myers Squibb position peaked at $3.03M in Q4 2020.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.